SCHEMBL9942423

SCHEMBL9942423

OCc1cc(CC(O)NCCCCCCOCCCC(F)(F)c2ccccc2)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 19/20 0.46
ADRB3 P13945 14/20 0.46
ADRB1 P08588 14/20 0.46
SLC6A2 P23975 2/20 0.46
HTR2A P28223 2/20 0.46
SLC6A4 P31645 2/20 0.46
ADRA1A P35348 2/20 0.46
SLC6A3 Q01959 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HTR1A P08908 1/20 0.46
CHRM5 P08912 1/20 0.46
DRD2 P14416 1/20 0.46
ADRA2B P18089 1/20 0.46
DRD4 P21917 1/20 0.46
FPR3 P25089 1/20 0.46
ADRA1D P25100 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46
HTR2C P28335 1/20 0.46
GPR183 P32249 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17185976 0.96 ADRB2 (0.46) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL2516327 0.91 ADRB2 (0.45) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL23931055 0.84 ADRB2 (0.64) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL2131341 0.83 ADRB2 (0.36) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL9942398 0.83 ADRB2 (0.36) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL2131348 0.83 ADRB2 (0.36) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL9942332 0.83 ADRB2 (0.49) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL9942772 0.83 ADRB2 (0.46) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL9942356 0.82 ADRB2 (0.43) ADRB2ADRB3ADRB1SLC6A2HTR2A
SCHEMBL9942325 0.81 ADRB2 (0.52) ADRB2ADRB3ADRB1SLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2736886-A1 SUBSTITUTED QUINOLINES AND THEIR USE AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2014-06-04 EP disclosed
EP-2651932-A1 BICYCLIC RING SYSTEM SUBSTITUTED SULFONAMIDE FUNCTIONALISED PHENOLS AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2013-10-23 EP disclosed
EP-2651891-A1 BICYCLIC RING SYSTEM SUBSTITUTED AMIDE FUNCTIONALISED PHENOLS AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2013-10-23 EP disclosed
WO-2013014060-A1 SUBSTITUTED QUINOLINES AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-31 WO disclosed
WO-2012080457-A1 BICYCLIC RING SYSTEM SUBSTITUTED SULFONAMIDE FUNCTIONALISED PHENOLS AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-21 WO disclosed
WO-2012080456-A1 BICYCLIC RING SYSTEM SUBSTITUTED AMIDE FUNCTIONALISED PHENOLS AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-21 WO disclosed